A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura
Status:
Completed
Trial end date:
2018-08-14
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the longer term safety of the study drug known
as galcanezumab in participants with episodic or chronic migraine.